Impressive Earnings May Not Tell The Whole Story For Dr. Agarwal's Health Care (NSE:AGARWALEYE)
NiveshIQ
NSE: AGARWALEYE · Healthcare
Dr. Agarwal's Health Care Ltd.
₹488.80▼ ₹4.30 (-0.87%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on AGARWALEYE. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Dr. Agarwal's Health Care Ltd.
Dr. Agarwal's Health Care Limited operates a network of eye hospitals in India and internationally, offering a range of surgical and non-surgical eye care services, including cataract, refractive, and retinal surgeries, as well as diagnostic services and eye care products. The company's core business is driven by its ability to provide high-quality eye care services, with a strong focus on technology and innovation. Recent developments include the closure of the trading window for Q1FY27 results, as well as positive recommendations from Motilal Oswal Financial Services Ltd, which has set a target price of ₹610. The company's competitive position is strengthened by its strong brand reputation and extensive network of hospitals. Dr. Agarwal's Health Care Limited has reported revenue of ₹2080
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,328 Cr +30.40% | ₹1,711 Cr +28.90% | ₹2,080 Cr +21.60% |
| EBITDA Margin | 28.89% | 26.71% | 29.52% |
| Net Profit | ₹83.06 Cr -19.40% | ₹110.00 Cr +32.40% | ₹166.81 Cr +51.60% |
| EPS | – | ₹1.75 | ₹4.21 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Dr. Agarwal's Health Care To Hold Q1 Earnings Call On August 4 At 5:30 PM
Dr. Agarwal's Health Care Q1 Results: Earnings call set for Aug 4
🔒
+ 3 more stories about Dr. Agarwal's Health Care Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹564 Cr, PAT ₹49 Cr, EPS ₹1.25, EBITDA margin 30.9%. Growth context: revenue YoY +22.6%, PAT YoY +13.1%, revenue QoQ +6.4%, PAT QoQ +10.5%. Street verdict: inline, revenue surprise +0.4%, PAT surprise -4.5%.
Management's near-term growth strategy hinges on product launches, approvals, and therapy-mix improvement, which are exp...
FY26 (last completed FY): revenue ₹2, 080 Cr, PAT ₹167 Cr, EBITDA margin 29.5%, EPS ₹4.21. Year-on-year: revenue YoY +21...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for AGARWALEYE
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track AGARWALEYE alongside your other holdings
Unlock full AGARWALEYE research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Dr. Agarwal's Health Care Ltd.?
NiveshIQ detects active intelligence signals for Dr. Agarwal's Health Care Ltd. (AGARWALEYE) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Dr. Agarwal's Health Care Ltd.?
Dr. Agarwal's Health Care Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,437,403.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.